1,809
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC–MS/MS

, , &
Pages 132-137 | Received 07 Nov 2017, Accepted 15 Jan 2018, Published online: 01 Feb 2018

References

  • Adake P, Somashekar HS, Mohammed Rafeeq PK, Umar D, Basheer B, Baroudi K. 2015. Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study. J Adv Pharm Technol Res. 6:81–85.
  • Agrawal H, Aggarwal K, Littrell R, Velagapudi P, Turagam MK, Mittal M, Alpert MA. 2015. Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev. 11:261–269.
  • Ahmad R, Shihab PK, Jasem S, Behbehani K. 2014. FSL-1 Induces MMP-9 production through TLR-2 and NF-κB /AP-1 signaling pathways in monocytic THP-1 cells. Cell Physiol Biochem. 34:929–942.
  • Brinker AM, Raskin I. 2005. Determination of triptolide in root extracts of Tripterygium wilfordii by solid-phase extraction and reverse-phase high-performance liquid chromatography. J Chromatography A. 1070:65–70.
  • Feldman L, Vinker S, Efrati S, Beberashvili I, Gorelik O, Wasser W, Shani M. 2016. Amlodipine treatment of hypertension associates with a decreased dementia risk. Clin Exp Hypertens. 38:545–549.
  • Glesby MJ, Aberg JA, Kendall MA, Fichtenbaum CJ, Hafner R, Hall S, Grosskopf N, Zolopa AR, Gerber JG. 2005. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clin Pharmacol Ther. 78:143–153.
  • Hotha KK, Roychowdhury S, Mullangi R, Ravindranath LK. 2013. Rapid quantification of amlodipine enantiomers in human plasma by LC-MS/MS: application to a clinical pharmacokinetic study. Biomed Chromatogr. 27:1192–1199.
  • Hsiao HL, Langenickel TH, Greeley M, Roberts J, Zhou W, Pal P, Rebello S, Rajman I, Sunkara G. 2015. Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol. Clin Pharmacol Drug Dev. 4:407–417.
  • Jin MC, Chen XH, Ou-Yang XK. 2009. Simultaneous determination of triptolide, tripdiolide and tripterine in human urine by high-performance liquid chromatography coupled with ion trap atmospheric-pressure chemical ionization mass spectrometry. Biomed Chromatogr. 23:289–294.
  • Lee JE, van Heeswijk R, Alves K, Smith F, Garg V. 2011. Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother. 55:4569–4574.
  • Li W, Liu Y, He YQ, Zhang JW, Gao Y, Ge GB, Liu HX, Huo H, Liu HT, Wang LM, et al. 2008. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes. Xenobiotica. 38:1551–1565.
  • Li H, Liu L, Xie L, Gan D, Jiang X. 2017. Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 55:1863–1867.
  • Liu Z, Ma L, Zhou GB. 2011. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules. 16:5283–5297.
  • Mao SJ, Huang XM. 2016. Tripterygium wilfordii Hook F is efficacious in the treatment of Henoch–Schönlein purpura nephritis in children. World J Pediatr. 12:375–376.
  • Meredith PA, Elliott HL. 1992. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 22:22–31.
  • Naito T, Kubono N, Ishida T, Deguchi S, Sugihara M, Itoh H, Kanayama N, Kawakami J. 2015. CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine. Drug Metab Pharmacokinet. 30:419–424.
  • Park B. 2014. Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells. Biochimie. 105:129–136.
  • Park JS, Rehman SU, Kim IS, Choi MS, Na CS, Yoo HH. 2017. Evaluation of herb–drug interactions of Hovenia dulcis fruit extracts. Pharmacogn Mag. 13:236–239.
  • Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
  • Qin CZ, Ren X, Tan ZR, Chen Y, Yin JY, Yu J, Qu J, Zhou HH, Liu ZQ. 2014. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 28:197–203.
  • Ryu SH, Kim JW, Kim YS, Lee SH, Cho YB, Lee HK, Kim YG, Jeong WS, Kim KB. 2014. Negligible pharmacokinetic interaction of red ginseng and antihypertensive agent amlodipine in Sprague–Dawley rats. J Toxicol Environ Health Part A. 77:1372–1383.
  • Shao F, Wang G, Xie H, Zhu X, Sun J, A J. 2007. Pharmacokinetic study of triptolide, a constituent of immunosuppressive Chinese herb medicine, in rats. Biol Pharm Bull. 30:702–707.
  • Son H, Lee D, Lim LA, Jang SB, Roh H, Park K. 2014. Development of a pharmacokinetic interaction model for co-administration of simvastatin and amlodipine. Drug Metab Pharmacokinet. 29:120–128.
  • Stopher DA, Beresford AP, Macrae PV, Humphrey MJ. 1988. The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol. 7:S55–S59.
  • Wang Q, Meng J, Dong A, Yu JZ, Zhang GX, Ma CG. 2016. The pharmacological effects and mechanism of Tripterygium wilfordii Hook. f. in central nervous system autoimmunity. J Altern Complement Med. 22:496–502.
  • Wang R, Zhang H, Sun S, Wang Y, Chai Y, Yuan Y. 2015. Effect of ginkgo leaf tablets on the pharmacokinetics of amlodipine in rats. Eur J Drug Metab Pharmacokinet. 41:825–833.
  • Wang XF, Zhao YB, Wu Q, Sun ZH, Li HJ. 2014. Triptolide induces apoptosis in endometrial cancer via a p53 independent mitochondrial pathway. Mol Med Rep. 9:39–44.
  • Wei D, Huang Z. 2014. Anti-inflammatory effects of triptolide in LPS-induced acute lung injury in mice. Inflammation. 37:1307–1316.
  • Yang SH, Cho YA, Choi JS. 2011. Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats. Acta Pharmacol Sin. 32:967–972.
  • Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF. 2006. Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des. 12:4649–4664.
  • Zhang H, Ya G, Rui H. 2017. Inhibitory effects of triptolide on human liver cytochrome p450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42:89–98.
  • Zhao W, Baudouin V, Fakhoury M, Storme T, Deschenes G, Jacqz-Aigrain E. 2012. Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child. Transplantation. 93:e29–e30.
  • Zheng X, Liu T, Chen X, Jiang J, Hu P. 2016. Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers. Int J Clin Pharmacol Ther. 54:43–51.
  • Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W. 2014. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos. 42:245–249.
  • Zuo XC, Zhou YN, Zhang BK, Yang GP, Cheng ZN, Yuan H, Ouyang DS, Liu SK, Barrett JS, Li PJ, et al. 2013. Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine. Drug Metab Pharmacokinet. 28:398–405.